Reuters -- Cephalon Inc said on Tuesday that two patients taking its new cancer drug Treanda developed a serious skin condition known as Stevens Johnson Syndrome and one has died.
Reuters -- Cephalon Inc said on Tuesday that two patients taking its new cancer drug Treanda developed a serious skin condition known as Stevens Johnson Syndrome and one has died.
